Table 1.
Patients who were hospitalized with AH and eligible but did not receive steroids, compared to those who were eligible and received steroids
| Contents | Steroids yes | Steroids no | P-value |
|---|---|---|---|
| Number of subjects | 201 | 110 | – |
| Age in years | 45.6 (11.2) | 48.9(10.3) | 0.008 |
| Female/Male | 103/98 | 53/57 | – |
| Race (AA/W/unknown) | 31/149/21 | 34/63/13 | – |
| Ethnicity % non-Hispanic | 91.54% | 86.36% | – |
| Weight in kg | 85.0 (24.4) | 82.1(22.7) | 0.299 |
| BMI kg/m2 | 30.0 (13.8) | 30.7(24.7) | 0.746 |
| Obesity (BMI ≥ 30 kg/m2) | 82 (41%) | 40 (36%) | 0.54 |
| Type 2 Diabetes Mellitus | 33 (16%) | 18 (16%) | 1.0 |
| MetALD | 97 (48%) | 50 (45%) | 0.81 |
| AST U/L | 215 (167) | 291(907) | 0.250 |
| ALT U/L | 59.7 (45.6) | 101(363) | 0.112 |
| Total bilirubin mg/dL | 18.4 (11.3) | 12.2(9.34) | 0.001 |
| Albumin g/dL | 2.68 (0.533) | 2.80(0.675) | 0.073 |
| PT sec | 22.3 (5.93) | 21.1(7.28) | 0.102 |
| INR | 1.98 (0.682) | 1.84(0.867) | 0.134 |
| Creatinine mg/dL | 1.09 (0.771) | 1.38(1.26) | 0.013 |
| MDF (using PT 13.5) | 59.1 (30.8) | 46.1(36.3) | 0.001 |
| MELD (admission) | 24.6 (7.69) | 26.(5.40) | 0.027 |
| MELD (discharge) | 26.4 (15.8) | 25.6(8.15) | 0.627 |
| 30-day survival rate | 89.05% | 80.90% | 0.058 |
AA African American, W white, BMI body mass index, MetALD metabolic dysfunction associated alcoholic liver disease, AST aspartate aminotransferase, ALT alanine aminotransferase, PT prothrombin time, INR international normalized ratio, MDF maddrey discriminatory function, MELD model for end stage liver disease